| The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c MMH Christensen, C Brasch-Andersen, H Green, F Nielsen, P Damkier, ... Pharmacogenetics and genomics 21 (12), 837-850, 2011 | 299 | 2011 |
| mdr-1 Single Nucleotide Polymorphisms in Ovarian Cancer Tissue: G2677T/A Correlates with Response to Paclitaxel Chemotherapy H Green, P Söderkvist, P Rosenberg, G Horvath, C Peterson Clinical Cancer Research 12 (3), 854-859, 2006 | 207 | 2006 |
| Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer H Green, P Söderkvist, P Rosenberg, RA Mirghani, P Rymark, ... Basic & clinical pharmacology & toxicology 104 (2), 130-137, 2009 | 165 | 2009 |
| Impact of CYP2C8* 3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer TK Bergmann, C Brasch-Andersen, H Green, M Mirza, RS Pedersen, ... PHARMACOGENOMICS JOURNAL 11 (2), 113-120, 0 | 126* | |
| Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia J Gregers, H Green, IJ Christensen, K Dalhoff, H Schroeder, N Carlsen, ... The pharmacogenomics journal 15 (4), 372-379, 2015 | 114 | 2015 |
| In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl S Watanabe, S Vikingsson, M Roman, H Green, R Kronstrand, ... The AAPS Journal 19, 1102-1122, 2017 | 111 | 2017 |
| Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer TK Bergmann, H Gréen, C Brasch-Andersen, MR Mirza, J Herrstedt, ... European journal of clinical pharmacology 67, 693-700, 2011 | 102 | 2011 |
| A reassessment of DNA-immunoprecipitation-based genomic profiling A Lentini, C Lagerwall, S Vikingsson, HK Mjoseng, K Douvlataniotis, ... Nature methods 15 (7), 499-504, 2018 | 93 | 2018 |
| Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy LJ Leandro-García, L Inglada-Pérez, G Pita, E Hjerpe, S Leskelä, C Jara, ... Journal of medical genetics 50 (9), 599-605, 2013 | 82 | 2013 |
| Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy LJ Leandro-García, S Leskelä, C Jara, H Gréen, E Åvall-Lundqvist, ... Clinical Cancer Research 18 (16), 4441-4448, 2012 | 79 | 2012 |
| Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice AJ Lopez-Contreras, J Specks, JH Barlow, C Ambrogio, C Desler, ... Genes & development 29 (7), 690-695, 2015 | 78 | 2015 |
| Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype H Green, IJ Falk, K Lotfi, E Paul, M Hermansson, R Rosenquist, C Paul, ... The pharmacogenomics journal 12 (2), 111-118, 2012 | 68 | 2012 |
| ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel H Green, P Söderkvist, P Rosenberg, G Horvath, C Peterson Journal of pharmaceutical sciences 97 (6), 2045-2048, 2008 | 66 | 2008 |
| Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer H Blomstrand, U Scheibling, C Bratthäll, H Green, NO Elander BMC cancer 19, 1-9, 2019 | 63 | 2019 |
| Identification of AKB-48 and 5F-AKB-48 metabolites in authentic human urine samples using human liver microsomes and time of flight mass spectrometry S Vikingsson, M Josefsson, H Green Journal of analytical toxicology 39 (6), 426-435, 2015 | 56 | 2015 |
| Pharmacogenetics, plasma concentrations, clinical signs and EEG during propofol treatment MS Khan, EL Zetterlund, H Gréen, A Oscarsson, AL Zackrisson, ... Basic & clinical pharmacology & toxicology 115 (6), 565-570, 2014 | 56 | 2014 |
| Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia K Willander, IJ Falk, R Chaireti, E Paul, M Hermansson, H Gréen, K Lotfi, ... Biomarker research 2, 1-9, 2014 | 56 | 2014 |
| Impact of ABCB1 Variants on Neutrophil Depression: A Pharmacogenomic Study of Paclitaxel in 92 Women with Ovarian Cancer TK Bergmann, C Brasch‐Andersen, H Gréen, MR Mirza, K Skougaard, ... Basic & clinical pharmacology & toxicology 110 (2), 199-204, 2012 | 54 | 2012 |
| 5F‐MDMB‐PICA metabolite identification and cannabinoid receptor activity MT Truver, S Watanabe, A Åstrand, S Vikingsson, H Green, ... Drug Testing and Analysis 12 (1), 127-135, 2020 | 53 | 2020 |
| Fatal poisonings associated with new psychoactive substances R Kronstrand, D Guerrieri, S Vikingsson, A Wohlfarth, H Gréen New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical …, 2018 | 51 | 2018 |
